.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
1906 has shown a strong and consistent performance in the Capsules category across multiple states, maintaining the top rank in Illinois, Massachusetts, Missouri, New Jersey, and New York from January to April 2025. Despite some fluctuations in sales figures, such as a noticeable dip in New York from January to April, the brand's position remains unchallenged in these markets. This suggests a strong brand loyalty and an effective market strategy in the Capsules category, allowing 1906 to dominate consistently.
In the Edible category, however, 1906's performance in New York has not mirrored the success seen in Capsules. Ranking between 21st and 24th from January to April, the brand has struggled to break into the top 20, indicating a competitive landscape and potential challenges in gaining a larger market share. The slight increase in sales from March to April suggests some positive movement, but without a top 30 presence in other states, this category remains a potential area for growth and improvement for 1906.
Competitive Landscape
In the New York capsules category, 1906 has maintained its leading position from January to April 2025, consistently ranking 1st. Despite a slight decline in sales from January's peak, 1906 remains significantly ahead of its competitors. Level, the closest competitor, has held the 2nd position throughout the same period, with sales figures considerably lower than 1906's, indicating a strong market dominance by 1906. Meanwhile, Etain, which ranked 3rd in February, did not appear in the top 20 for the other months, suggesting a less consistent market presence. This stability in rank and relative sales performance underscores 1906's robust brand strength and consumer preference in the New York capsules market.
Notable Products
In April 2025, the top-performing product for 1906 remained the CBD/THC 1:1 Bliss Tablets 20-Pack, consistently holding the number one rank since January, with sales reaching 18468. The Boost Drops Pills 20-Pack also maintained its second place position throughout the first four months of 2025. Notably, the CBD/THC 5:1 Chill Tablets 20-Pack improved its ranking to third place in April, up from fifth in March, showing a significant sales increase. The CBD/THC 1:1 Go Drop Tablets held steady at fourth place, following a rise from fifth in February. Meanwhile, the CBD/THC/CBN 2:2:1 Sleep for ZZZ'S Drops saw a decline to fifth place in April, after reaching as high as third in March.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
